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INTRODUCTION
Wegener’s Granulomatosis (WG) 
is an idiopathic systemic granulomatous 
vasculitis, probably of autoimmune origin, 
characterized by necrotizing granulomas in 
the lower airways, genitourinary tract and 
upper airways (UAW), associated with some 
degree of disseminated vasculitis.
Having an incidence of up to 
3/100,000 inhabitants, its evolution can be 
indolent or fulminant and, if left untreated, it 
has a mortality rate of 82% in one year.
The UAW involvement happens in 
about 90% of the cases at some stage of 
the disease, and the oral cavity is the most 
commonly affected site. We hardly ever find 
suppurative otitis media as initial manifes-
tation1-4.
CASE REPORT
A 42-year-old Caucasian woman, 
with intense otalgia and purulent otorrhea 
on the right side for 45 days, had a disorder 
which was refractory to the use of numerous 
antibiotic agents (amoxicillin-clavulanic acid, 
ciprofloxacin and ceftriaxone), associated 
with systemic and topical steroids. She deve-
loped vertigo, headache and mixed-severe 
right side hearing loss.
As prior history, she had renal dys-
function of unknown origin and a kidney 
transplanted sister.
She had central perforation on her 
right-side tympanic membrane, where we 
could see a red tumor suggesting a polyp and 
purulent otorrhea. The other otorhinolaryn-
gological exams were normal.
Laboratorial findings showed an 
otorrhea secretion with the growth of pneu-
mococcus sensitive to the antibiotic agents 
used, CBC showing neutrophilia and left side 
shifting, increased VHS and proteinuria.
Temporal bone CT-scan (Figure 1A) 
showed blurring of the tympanic cavity and 
of the mastoid cells; and skull MRI (Figure 
1B) showed a hyperintensity signal in T2 on 
the right mastoid bone.
Since there was no clinical response, 
tympanomastoidectomy was indicated, toge-
ther with the placement of a ventilation tube 
on the right side with the goal of eliminating 
the inflammatory process and to collect ma-
terial for histopathology.
On the seventh postoperative day, 
the patient developed progressive ipsilateral 
peripheral facial paralysis, and she also had 
a worsening on her left-side hearing, stress 
dyspnea and mucous and bloody rhinorrhea. 
Nasal-fibroscopy also showed ulcerations co-
vered by fibrin in the bilateral torus tubarius 
and on the lateral wall of the right nasal cavity.
Chest x-ray (Figure 1C) showed a reti-
culonodular infiltrate in the bases of the lung.
Histopathology showed the presence 
of granulomas (Figure 1D). We then ordered 
the anti-neutrophil cytoplasmic antibody 
(ANCA-c), which was positive all the way to 
1/160 titer, confirming the diagnosis of WG.
Then we started treatment with de-
flazacort and cyclophosphamide, and the 
patient had an important improvement in her 
general health and a progressive recovery of 
her hearing and facial paralysis.
Since then, for about 21 months, the 
patient has been receiving treatment with 
cyclophosphamide with disease remission.
DISCUSSION
In order to properly diagnose WG, 
one must have a high degree of suspicion, 
especially in patients with refractory disease, 
with the involvement of numerous organs and 
systems and worsening in the general status.
Besides detailing the clinical situation, 
one must order a chest x-ray and biochemical 
tests, including serology tests.
Biopsy with histopathology is the 
gold standard. In the head and neck region, 
often times it is necessary to obtain a proper 
sample. This should show unspecific in-
flammatory granulomas, with gigantic cells, 
small-vessel vasculitis, irregular necrosis areas 
and the presence of an acute and chronic 
inflammatory process coexisting.
ANCA-c has a sensitivity of 90% and 
a specificity of 99%, and the disease activity 
is associated the higher titers.
Treatment requires a multidiscipli-
nary approach and is based on the use of 
immunosuppressive medication such as 
cyclophosphamide, methotrexate and high 
doses of steroids.
Associated with that, there are clinical 
and surgical measures which aim at reducing 
morbidity, improving the life quality of those 
with the disorder3-6.
FINAL REMARKS
Because of the high involvement of 
UAWs in WGs and sometimes manifesting 
early and atypical manifestations, such as in 
the case hereby described, the ENT physician 
plays a determining role in establishing a 
correct diagnosis and immediate treatment, 
thus crucially working towards a diagnostic 
change for those with the disease.
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Figure 1. A- Right-side temporal bone CT-scan, showing a blurring 
of the tympanic cavity; B-Skull MRI in T2 with hyperintensity signal 
on the right-side mastoid; C- Chest X-Ray with reticulonodular 
infiltrate in the bases of the lung; D- histopathology study showing 
the granulomas (arrows).
